Blar i NTNU Open på forfatter "Halvorsen, Tarje Onsøien"
-
Thoracic radiotherapy in limited disease small cell lung cancer
Halvorsen, Tarje Onsøien (Doctoral theses at NTNU;2017:7, Doctoral thesis, 2017)Norsk sammendrag: Lungekreft er den tredje hyppigste kreftformen, og den ledende årsaken til kreftrelaterte dødsfall. Småcellet lungekreft (SCLC) er den mest aggressive av to hovedtyper lungekreft, og forekommer nesten ... -
Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018
Graabak, Gustav; Grønberg, Bjørn Henning; Sandvei, Marie Søfteland; Nilssen, Yngvar; Halvorsen, Tarje Onsøien (Peer reviewed; Journal article, 2022)Introduction Twice-daily (BID) thoracic radiotherapy (TRT) of 45 Gy per 30 fractions is recommended for limited-stage (LS) SCLC, but most patients are treated with once-daily (OD) schedules owing to toxicity concerns ... -
Timing of severe toxicity from chemotherapy in patients with lung cancer
Sjøgren, Kristina; Jacobsen, Kristian Aalberg; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien (Journal article; Peer reviewed, 2020)Background/Aim: The aim of this study was to investigate the timing of severe toxicity in lung cancer patients receiving chemotherapy. Patients and Methods: Patients with advanced non-small cell lung cancer or limited ... -
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC
Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien (Peer reviewed; Journal article, 2023)Introduction Half of the patients with limited-stage SCLC (LS SCLC) are above or equal to 70 years old, but they account for less than 20% of participants in most trials. Comorbidities and reduced organ and physical ... -
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer
Halvorsen, Tarje Onsøien; Herje, Martin; Levin, Nina; Bremnes, Roy M.; Brustugun, Odd Terje; Fløtten, Øystein; Kaasa, Stein; Sundstrøm, Stein Harald; Grønberg, Bjørn Henning (Journal article; Peer reviewed, 2016)Objectives Concurrent chemotherapy and thoracic radiotherapy (TRT) is recommended for limited disease small-cell lung cancer (LD SCLC). TRT should start as early as possible, often meaning with the second course due to ... -
Twice-daily thoracic radiotherapy in limited stage small-cell lung cancer
Killingberg, Kristin Toftaker (Doctoral theses at NTNU;2023:156, Doctoral thesis, 2023)Norsk sammendrag Lungekreft er den kreftformen som forårsaker flest dødsfall. Lungekreft deles inn i to hovedtyper, ikke-småcellet (NSCLC) og småcellet lungekreft (SCLC). SCLC utgjør 13-15% av tilfellene og kjennestenges ...